Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C42H62N2O4S |
Molecular Weight | 691.018 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 9 / 9 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@]12[C@@H](CC[C@@]1(CC[C@]3(C)[C@]2([H])CC[C@]4([H])[C@@]5(C)CC=C(C6=CC=C(C=C6)C(O)=O)C(C)(C)[C@]5([H])CC[C@@]34C)NCCN7CCS(=O)(=O)CC7)C(C)=C
InChI
InChIKey=XDMUFNNPLXHNKA-ZTESCHFWSA-N
InChI=1S/C42H62N2O4S/c1-28(2)31-14-19-42(43-22-23-44-24-26-49(47,48)27-25-44)21-20-40(6)33(36(31)42)12-13-35-39(5)17-15-32(29-8-10-30(11-9-29)37(45)46)38(3,4)34(39)16-18-41(35,40)7/h8-11,15,31,33-36,43H,1,12-14,16-27H2,2-7H3,(H,45,46)/t31-,33+,34-,35+,36+,39-,40+,41+,42-/m0/s1
Molecular Formula | C42H62N2O4S |
Molecular Weight | 691.018 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 8 / 9 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:20:11 GMT 2023
by
admin
on
Sat Dec 16 10:20:11 GMT 2023
|
Record UNII |
4CA9IAU7RJ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
4CA9IAU7RJ
Created by
admin on Sat Dec 16 10:20:11 GMT 2023 , Edited by admin on Sat Dec 16 10:20:11 GMT 2023
|
PRIMARY | |||
|
SUB197797
Created by
admin on Sat Dec 16 10:20:11 GMT 2023 , Edited by admin on Sat Dec 16 10:20:11 GMT 2023
|
PRIMARY | |||
|
BMS-955176
Created by
admin on Sat Dec 16 10:20:11 GMT 2023 , Edited by admin on Sat Dec 16 10:20:11 GMT 2023
|
PRIMARY | |||
|
DB15193
Created by
admin on Sat Dec 16 10:20:11 GMT 2023 , Edited by admin on Sat Dec 16 10:20:11 GMT 2023
|
PRIMARY | |||
|
DTXSID401336145
Created by
admin on Sat Dec 16 10:20:11 GMT 2023 , Edited by admin on Sat Dec 16 10:20:11 GMT 2023
|
PRIMARY | |||
|
1392312-45-6
Created by
admin on Sat Dec 16 10:20:11 GMT 2023 , Edited by admin on Sat Dec 16 10:20:11 GMT 2023
|
PRIMARY | |||
|
60152109
Created by
admin on Sat Dec 16 10:20:11 GMT 2023 , Edited by admin on Sat Dec 16 10:20:11 GMT 2023
|
PRIMARY | |||
|
100000183335
Created by
admin on Sat Dec 16 10:20:11 GMT 2023 , Edited by admin on Sat Dec 16 10:20:11 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
TARGET ORGANISM->INHIBITOR |
The observation of gastrointestinal intolerability and the emergence of resistant virus led to the cessation of development activities in favor of compounds with improved antiviral profiles.
EC50
|
||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |